Breaks Categories: News

ThursdayAug 15, 2024 11:51 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the second quarter ended June 30, 2024 (“Q2 2024”). The company also discussed the clinical development progress of Berubicin, its lead program, and TPI 287, its recently in-licensed abeotaxane for the treatment of brain malignancies. CNS Pharmaceutical expects to be able to release final topline data from its potentially pivotal trial of Berubicin in the first half of 2025. The trial is evaluating Berubicin in adult patients with…

Continue Reading

ThursdayAug 15, 2024 11:32 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports on Voting Results of 2024 Annual and Special Meeting of Shareholders

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, is reporting on its 2024 Annual and Special Meeting of Shareholders. The meeting. According to the announcement, shareholders voted on and approved all five proposals on the agenda. Proposals included the election of four directors to the company’s board of directors; the reappointment of Davidson & Company LLP, an independent registered public accounting firm, as the company auditors; amending FLGC’s Incentive Compensation Plan to increase the issuable number of shares; granting stock appreciation rights to the company's CEO and CFO; and issuing 635,363 shares in accordance with NASDAQ guidelines…

Continue Reading

ThursdayAug 15, 2024 11:03 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today published its financial results for the second quarter ended June 30, 2024, and provided a business update. Scinai plans to host a webinar to discuss its Q2 2024 results and business update on August 20, 2024, at 11 a.m. EDT/6 p.m. Israel Time. Recent highlights from Q2 2024 included the signing of an agreement to restructure a $29 million bank loan to equity and plans to regain Nasdaq compliance by…

Continue Reading

ThursdayAug 15, 2024 9:52 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Q2 2024 Financial Results, Provides Update Showing ‘Productive’ Recent Months

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today released financial results for its second quarter ended June 30, 2024, and provided a business update. According to the update, results from the company’s completed Phase 2/3 AD study showed that buntanetap significantly improved cognition in patients with early AD. Additionally, data from its Phase 3 PD study revealed that buntanetap led to improvements in both the Unified Parkinson’s Disease Rating Scale (“MDS-UPDRS”) and cognition across several PD subpopulations. The company also discussed the filing of patents, team…

Continue Reading

WednesdayAug 14, 2024 3:21 pm

NetworkNewsBreaks – Blockchain Africa Conference 2024 to Continue Decade’s Work of Propelling Africa to the Forefront of Global Blockchain Revolution

Blockchain Africa Conference, Africa’s largest and most influential blockchain event, is back, celebrating its monumental 10th anniversary. Organized by Bitcoin Events, this milestone event is where the future of Africa’s blockchain ecosystem is forged. This year marks a decade of groundbreaking innovation, transformative conversations, and game-changing solutions that are propelling Africa to the forefront of the global blockchain revolution. Attendees can look forward to an exhilarating lineup of keynotes, interactive exhibitions, hands-on workshops, and two action-packed tracks in the main program. The conference will feature a distinguished roster of speakers who will cover an expansive range of topics, including AI…

Continue Reading

WednesdayAug 14, 2024 3:05 pm

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Given $21.00 Price Target by EF Hutton

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), recently had its price target set at $21.00. The price target was issued by Jason Kolbert from EF Hutton on August 13, 2024. At the time of the announcement, Annovis Bio was trading at $7.87. “The overall price target consensus is at $26.00 with high price of $26.00, low price of $26.00, and median price is at $26.00,” the report reads. To view the full report, visit https://nnw.fm/p3ZGP About Annovis Bio Inc. Annovis Bio is headquartered in Malvern, Pennsylvania,…

Continue Reading

WednesdayAug 14, 2024 2:45 pm

NetworkNewsBreaks – Blockchain Futurist Conference Anchors Upcoming Canada Crypto Week

Blockchain Futurist Conference is the anchor event for this month’s Canada Crypto Week, a weeklong series of Web3 and artificial intelligence (“AI”) events. Blockchain Futurist Conference will be providing a central hub for the weeklong event series that includes more than 30 web3 subevents, including networking events, round table discussions, book signings, investor breakfasts and more. Canada Crypto Week is slated for Aug. 11–17, 2024, in Toronto. According to the announcement, many of the events during Canada Crypto Week will take place at the Blockchain Futurist Conference site, offering attendees an interactive and immersive experience. Some of the week’s events include the…

Continue Reading

WednesdayAug 14, 2024 2:10 pm

NetworkNewsBreaks – NextPlat Corp. (NASDAQ: NXPL), Progressive Care (RXMD) Release Q2 2024 Financial Results Showing 474% Revenue Increase

NextPlat (NASDAQ: NXPL), a global e-Commerce provider, has released record financial results for its second fiscal quarter, the period ended June 30, 2024; the results include the consolidation of the operations of its e-commerce business with the results of its healthcare operations, Progressive Care Inc. (OTCQB: RXMD). Highlights of the report indicate the company experienced a 474% increase in consolidated Q2 revenues, which totaled $17 million, and a record 34.2% quarterly margins; the report noted that the company anticipates reaching $70 million in 2024 annual revenues with additional healthcare services contracts and E-commerce expansion expected to drive the company’s continued growth. “We are…

Continue Reading

WednesdayAug 14, 2024 1:37 pm

NetworkNewsBreaks – Greenlane Holdings Inc. (NASDAQ: GNLN) Executes $6.5M Private Placement

Greenlane Holdings (NASDAQ: GNLN) has transacted a $6.5 million private placement priced at-the-market. Greenlane operates in two segments: consumer goods and industrial goods. The company is involved in developing and distributing vape devices, cannabis accessories and lifestyle products throughout the United States, Canada, and Europe. Aegis Capital Corp. acted as exclusive placement agent for the private placement. Involved in the wealth-management and investment-banking business, Aegis is dedicated to providing corporate-finance, strategic-advisory and related services to public and private companies across multiple sectors and regions. To view the full press release, visit https://nnw.fm/FvhiF About Greenlane Holdings Inc. Greenlane Holdings engages in…

Continue Reading

WednesdayAug 14, 2024 1:21 pm

NetworkNewsBreaks – Alliance Creative Group, Inc. (ACGX) Announces Q2 2024 Financial Results

Alliance Creative Group (OTC: ACGX), a parent holding company, today released the results for the second quarter ended June 30, 2024 (“Q2 2024”). Key numbers included revenues of $159,617, gross profits of $159,617, and net income of $78,843. The total assets on the company’s balance sheet as of June 30, 2024, were $4,601,150. In addition, Alliance Creative Group ended Q2 2024 with $142,061 cash on hand. “The shares we own in www.PeopleVine.com have continued to be our strongest investment and asset. The conversations with some of the experienced and credible growth equity firms have progressed to the more enhanced due…

Continue Reading